1.
Prigenzi KCK, Barbosa L de F, Nova LGP, Filho AM dos S, Cruz AL da, Waitzberg AFL. Human epidermal growth factor receptor-type 2 status and tumor heterogeneity in invasive breast carcinomas: clinical pathological impact. MAST [Internet]. 2026 Feb. 24 [cited 2026 May 20];35(suppl.1). Available from: https://mastology.org/journal/article/view/1211